
Sign up to save your podcasts
Or
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
4.7
16081,608 ratings
AstraZeneca’s vaccine gets UK approval, but the FDA has yet to decide. Bill Barker analyzes that story, reacts to 2021 precitions about the price of oil and a return to domestic travel, and shares why future investors might not realize how crazy 2020 was for the stock market.
4,081 Listeners
495 Listeners
3,195 Listeners
826 Listeners
2,174 Listeners
1,362 Listeners
3,366 Listeners
805 Listeners
1,489 Listeners
937 Listeners
2,317 Listeners
590 Listeners
383 Listeners
884 Listeners
1,545 Listeners
415 Listeners
236 Listeners